The board of SyntheticMR AB (publ) has today decided to appoint Vedran Beglerbegovic as Acting CEO with immediate effect, due to the current CEO, Ulrik Harrysson, being on sick leave indefinitely. Vedran Beglerbegovic, who currently holds the position of COO within the company, will lead the operations during Ulrik Harrysson’s absence.

Vedran Beglerbegovic has been part of SyntheticMR since 2021.

For further information, please contact:

Vedran Beglerbegovic, Acting CEO                  
Phone: 079-0772720
E-mail: vedran.beglerbegovic@syntheticmr.com

Staffan Persson, Chairman of the board               
Phone: 070-3210098
E-mail: sp@swediacapital.se

SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR AB has developed SyMRI^®, delivering multiple, adjustable contrast images and quantitative data from a single 5-minute scan. The SyMRI product is available in different packages. SyMRI NEURO delivers multiple contrast images, tissue segmentations and quantitative data on the brain. SyMRI MSK provides multiple contrast images and quantitative data for knee and spine anatomies. SyMRI NEURO is CE-marked and FDA 510(k) cleared and SyMRI MSK is CE-marked. SyMRI is a registered trademark in Europe and the USA. SyntheticMR is listed on the Spotlight Stock Market Exchange in Stockholm, Sweden. For more information, visit www.syntheticmr.com.